Expert: Once daily oral alpha-4/beta-7 integrin inhibitor for inflammatory bowel disease. Oral alternative to injectable vedolizumab (Entyvio).

Everyday: Blocks immune cells from traveling to the gut, reducing inflammation in bowel diseases.

Targets: ["A4B7"]